Singapore markets closed
Straits Times Index
3,290.70 +24.75 (+0.76%) Nikkei
38,229.11 +155.13 (+0.41%) Hang Seng
18,963.68 +425.87 (+2.30%) FTSE 100
8,433.76 +52.41 (+0.63%) Bitcoin USD
60,907.33 -2,058.40 (-3.27%) CMC Crypto 200
1,261.04 -96.97 (-7.14%)
ViaDerma, Inc. (VDRM)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
At close: 03:43PM EDT
| Previous close | 0.0092 |
| Open | 0.0085 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 0.0083 - 0.0089 |
| 52-week range | 0.0080 - 0.0180 |
| Volume | |
| Avg. volume | 1,309,440 |
| Market cap | 78,388 |
| Beta (5Y monthly) | -0.04 |
| PE ratio (TTM) | 0.03 |
| EPS (TTM) | 0.2700 |
| Earnings date | 01 Apr 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
GlobeNewswireViaDerma Update on Stability Testing, Global Sales Distribution, National Licensing, Nupelo & More
LOS ANGELES, Calif., Oct. 24, 2023 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink: VDRM) is pleased to announce several new and exciting business updates for current and prospective shareholders, customers, partners, and healthcare providers. The company is currently in the final phases of completing our stability testing requirements with our third-party testing facility. Based on the feedback we received from our testing partner last week, the company is on pace to have everything finalized by t
© 2024 Yahoo. All rights reserved.